Interplay between inflammation and degeneration: using inclusion body myositis to study "neuroinflammation"

Ann Neurol. 2008 Jul;64(1):1-3. doi: 10.1002/ana.21452.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Animals
  • Anti-Inflammatory Agents / pharmacology
  • Anti-Inflammatory Agents / therapeutic use
  • Antibodies, Monoclonal / pharmacology
  • Antibodies, Monoclonal / therapeutic use
  • Encephalitis / immunology
  • Humans
  • Immunologic Factors / pharmacology
  • Immunologic Factors / therapeutic use
  • Immunotherapy / methods
  • Immunotherapy / trends
  • Inflammation Mediators / immunology
  • Inflammation Mediators / metabolism
  • Muscle, Skeletal / immunology
  • Myositis, Inclusion Body / drug therapy
  • Myositis, Inclusion Body / immunology*
  • Nerve Degeneration / immunology*
  • Neurodegenerative Diseases / immunology*

Substances

  • Anti-Inflammatory Agents
  • Antibodies, Monoclonal
  • Immunologic Factors
  • Inflammation Mediators